- Home
- SYBX vs USEA Comparison
SYBX vs USEA Comparison
Compare SYBX & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- USEA
- Stock Information
- Founded
- SYBX N/A
- USEA 2004
- Country
- SYBX United States
- USEA Greece
- Employees
- SYBX N/A
- USEA N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- SYBX Health Care
- USEA Consumer Discretionary
- Exchange
- SYBX Nasdaq
- USEA Nasdaq
- Market Cap
- SYBX 16.5M
- USEA 16.1M
- IPO Year
- SYBX N/A
- USEA N/A
- Fundamental
- Price
- SYBX $1.36
- USEA $1.85
- Analyst Decision
- SYBX Hold
- USEA Strong Buy
- Analyst Count
- SYBX 1
- USEA 1
- Target Price
- SYBX N/A
- USEA $6.00
- AVG Volume (30 Days)
- SYBX 19.0K
- USEA 23.8K
- Earning Date
- SYBX 03-18-2025
- USEA 03-04-2025
- Dividend Yield
- SYBX N/A
- USEA 16.22%
- EPS Growth
- SYBX N/A
- USEA N/A
- EPS
- SYBX N/A
- USEA N/A
- Revenue
- SYBX $2,777,000.00
- USEA $46,160,000.00
- Revenue This Year
- SYBX N/A
- USEA $27.55
- Revenue Next Year
- SYBX N/A
- USEA $5.76
- P/E Ratio
- SYBX N/A
- USEA N/A
- Revenue Growth
- SYBX 292.23
- USEA 11.18
- 52 Week Low
- SYBX $1.22
- USEA $1.63
- 52 Week High
- SYBX $2.04
- USEA $3.00
- Technical
- Relative Strength Index (RSI)
- SYBX 45.23
- USEA 50.46
- Support Level
- SYBX $1.31
- USEA $1.85
- Resistance Level
- SYBX $1.40
- USEA $1.92
- Average True Range (ATR)
- SYBX 0.07
- USEA 0.04
- MACD
- SYBX 0.00
- USEA 0.00
- Stochastic Oscillator
- SYBX 60.61
- USEA 50.00
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.